CASE REPORT
Accepted on 21 Nov 2025
- Frontiers in Oncology
- Thoracic Oncology
- Research Topics
- Real-World Data and Real-World Evidence in Lung Cancer Volume II
Real-World Data and Real-World Evidence in Lung Cancer Volume II
2,153
Total downloads
19k
Total views and downloads
Articles
ORIGINAL RESEARCH
Accepted on 21 Nov 2025
Outcomes with Frontline Immune Checkpoint Inhibitors Among Individuals with BRAF-Mutant Non-Small Cell Lung Cancer
ORIGINAL RESEARCH
Published on 19 Nov 2025
Prognostic significance of the lymphocyte-to-high-density lipoprotein ratio in long-term efficacy of combined immunotherapy for advanced non-small cell lung cancer
doi 10.3389/fonc.2025.1712779
- 360 views
CASE REPORT
Published on 19 Nov 2025
Case Report: A case of necrotizing sarcoid granulomatosis mimicking metastatic tumor
doi 10.3389/fonc.2025.1703599
- 182 views
ORIGINAL RESEARCH
Accepted on 18 Nov 2025
Toripalimab as first-line treatment in extensive-stage small cell lung cancer: a health economic evaluation in China
ORIGINAL RESEARCH
Accepted on 10 Nov 2025
Impact of KRAS G12C mutation on the efficacy of chemoradiotherapy in patients with unresectable stage II or III non-small cell lung cancer
ORIGINAL RESEARCH
Accepted on 03 Nov 2025
Long-Term Outcomes and Patterns of Failure After Empiric SBRT for Presumed Early-Stage Lung Tumors
- 100 views
ORIGINAL RESEARCH
Published on 23 Oct 2025
Real-world survival patterns and multimodal therapy utilization in small cell lung cancer: a retrospective cohort study in a Chinese countryside hospital
doi 10.3389/fonc.2025.1636533
- 842 views
ORIGINAL RESEARCH
Published on 22 Oct 2025
Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world, multicenter observational study
doi 10.3389/fonc.2025.1647385
- 863 views
CASE REPORT
Published on 22 Oct 2025
Case Report: Analysis of short-term clinical efficacy of trilaciclib in patients with advanced lung neuroendocrine carcinoma undergoing chemotherapy
doi 10.3389/fonc.2025.1685910
- 724 views
CASE REPORT
Published on 20 Oct 2025
Different therapeutic responses to osimertinib as first-line treatment for cavitated and non-cavitated squamous cell lung cancer with rare EGFR exon 19 deletion: two case reports and a literature review
doi 10.3389/fonc.2025.1626665
- 1,224 views
ORIGINAL RESEARCH
Published on 17 Oct 2025
Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims data
doi 10.3389/fonc.2025.1650373
- 1,483 views
Published in
Frontiers in Oncology
Thoracic Oncology
Participating Journals
Frontiers in Public Health
- 3.4 impact factor
- 5.5 citescore